SCHEMBL20152337

SCHEMBL20152337

Nc1ccccc1N1c2ccccc2C(c2ccccc2)(c2ccccc2)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ GAA P10253 5/20 0.39
▸ USP2 O75604 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KEAP1 Q14145 1/20 0.36
▸ ADRA2C P18825 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ P2RX1 P51575 1/20 0.33
▸ P2RX3 P56373 1/20 0.33
▸ P2RX4 Q99571 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ PAX8 Q06710 1/20 0.33
▸ MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29833177 0.79 ALDH1A1 (0.41) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL2754763 0.79 ALDH1A1 (0.41) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL13231436 0.79 ALDH1A1 (0.37) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL19900154 0.78 MGLL (0.44) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL20152339 0.78 MGLL (0.44) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL19035959 0.77 LMNA (0.36) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL21387931 0.76 LMNA (0.41) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL20383358 0.76 ALDH1A1 (0.39) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL15030649 0.76 ALDH1A1 (0.39) MEN1KMT2AKDM4ELMNAMAPT
SCHEMBL14398805 0.74 FAAH (0.40) MEN1KMT2AKDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844059-B2 Heterocyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-11-24 — — US disclosed
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-17 — — US disclosed
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME OR10J3, HDAC10, RBM12 MEN1 2863/4885KMT2A 1167/4885KDM4E 565/4885
US-10844059-B2 Heterocyclic compound and organic electroluminescence device including the same OR10J3, HDAC10, RBM12 MEN1 2863/4885KMT2A 1167/4885KDM4E 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback